Walgreens Boots Alliance

Capital allocation decisions at Walgreens are made by the corporate finance and strategy team under the CEO and board of directors, not by a separate investment office. The current CEO is Tim Wentworth, who assumed the role in 2023 (per company filings). The company does not have an internal investment fund or CIO role similar to a family office.

Walgreens does not publicly report any allocation to external fund managers or direct co-investments as a financial investor. Its primary capital deployment is operational: building or acquiring stores, buying independent pharmacies, investing in healthcare partnerships (e.g., VillageMD), and technology upgrades. These are capital expenditures for the business, not an investment portfolio for third-party capital.

Walgreens' business is concentrated in community retail pharmacy, specialty pharmacy, healthcare services (including primary care through VillageMD and Shields Health Solutions), and international retail via Boots. It does not invest in unrelated sectors like technology, real estate, or venture capital; its activities are aligned with its healthcare and retail strategy.